NCT06700980 Options for Lowering the Threshold to Brussels Out-of-hours Primary Care Services for Dutch Speaking Citizens
| NCT ID | NCT06700980 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Universitair Ziekenhuis Brussel |
| Condition | Communication Barriers |
| Study Type | OBSERVATIONAL |
| Enrollment | 40 participants |
| Start Date | 2024-12-10 |
| Primary Completion | 2026-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 40 participants in total. It began in 2024-12-10 with a primary completion date of 2026-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this qualitative study is to find out which technological translation tools can be used to improve Dutch-speaking care in all Brussels out-of-hours primary care services.
Eligibility Criteria
Inclusion Criteria: * Patients: adult, living in Brussels, Dutch-speaking * GPs: adult, working in Brussels, Dutch- and/or French-speaking * Employees of professional organization-regulatory bodies: adult, Dutch-and/or French-speaking Exclusion Criteria: * Subject is not capable of will * Subject cannot express themself in Dutch or French
Contact & Investigator
Prof. Dr. A. Roex
PRINCIPAL INVESTIGATOR
Vrije Universiteit Brussel
Frequently Asked Questions
Who can join the NCT06700980 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Communication Barriers. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06700980 currently recruiting?
Yes, NCT06700980 is actively recruiting participants. Contact the research team at aurore.torsin@vub.be for enrollment information.
Where is the NCT06700980 trial being conducted?
This trial is being conducted at Jette, Belgium.
Who is sponsoring the NCT06700980 clinical trial?
NCT06700980 is sponsored by Universitair Ziekenhuis Brussel. The principal investigator is Prof. Dr. A. Roex at Vrije Universiteit Brussel. The trial plans to enroll 40 participants.